{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:08:53Z","timestamp":1787238533205,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Metastasectomy is a common treatment option for patients with colorectal lung metastases (CLM). Challenges exist with margin assessment and identification of small nodules, especially during minimally invasive surgery. Intraoperative fluorescence imaging has the potential to overcome these challenges. The aim of this study was to assess feasibility of targeting CLM with the carcinoembryonic antigen (CEA) specific fluorescent tracer SGM-101.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a prospective, open-label feasibility study. The primary outcome was the number of CLM that showed a true positive fluorescence signal with SGM-101. Fluorescence positive signal was defined as a signal-to-background ratio (SBR)\u2009\u2265\u20091.5. A secondary endpoint was the CEA expression in the colorectal lung metastases, assessed with the immunohistochemistry, and scored by the total immunostaining score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirteen patients were included in this study. Positive fluorescence signal with in vivo, back table, and closed-field bread loaf imaging was observed in 31%, 45%, and 94% of the tumors respectively. Median SBRs for the three imaging modalities were 1.00 (IQR: 1.00\u20131.53), 1.45 (IQR: 1.00\u20131.89), and 4.81 (IQR: 2.70\u20137.41). All tumor lesions had a maximum total immunostaining score for CEA expression of 12\/12.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrated the potential of fluorescence imaging of CLM with SGM-101. CEA expression was observed in all tumors, and closed-field imaging showed excellent CEA specific targeting of the tracer to the tumor nodules. The full potential of SGM-101 for in vivo detection of the tracer can be achieved with improved minimal invasive imaging systems and optimal patient selection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The study was registered in ClinicalTrial.gov under identifier NCT04737213 at February 2021.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00259-023-06365-3","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T02:01:46Z","timestamp":1691460106000},"page":"2970-2979","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Intraoperative molecular imaging of colorectal lung metastases with SGM-101: a feasibility study"],"prefix":"10.1007","volume":"51","author":[{"given":"Ruben P. J.","family":"Meijer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidde A.","family":"Galema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin A.","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okker D.","family":"Bijlstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P. W. M.","family":"Maat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Cailler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"Keereweer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise E.","family":"Hilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus","family":"Burggraaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Vahrmeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlijn","family":"Hutteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the SGM-CLM study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats I.","family":"Warmerdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feredun","family":"Azari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima D. A.","family":"Almandawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edris A. F.","family":"Mahtab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada M. M.","family":"Shahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Doukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9r\u00e9nice","family":"Framery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"key":"6365_CR1","first-page":"S742","volume":"2","author":"Y Meyer","year":"2021","unstructured":"Meyer Y, Olthof PB, Gr\u00fcnhagen DJ, de Hingh I, de Wilt JHW, Verhoef C, et al. Treatment of metachronous colorectal cancer metastases in the Netherlands: a population-based study. Eur J Surg Oncol. 2021;2:S742.","journal-title":"Eur J Surg Oncol."},{"key":"6365_CR2","doi-asserted-by":"publisher","first-page":"29765","DOI":"10.1038\/srep29765","volume":"6","author":"M Riihim\u00e4ki","year":"2016","unstructured":"Riihim\u00e4ki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6:29765.","journal-title":"Sci Rep"},{"key":"6365_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/oncolo\/oyac209","volume":"28","author":"Z Hao","year":"2022","unstructured":"Hao Z, Parasramka S, Chen Q, Jacob A, Huang B, Mullett T, et al. Neoadjuvant versus adjuvant chemotherapy for resectable metastatic colon cancer in non-academic and academic programs. Oncologist. 2022;28:48\u201358.","journal-title":"Oncologist"},{"key":"6365_CR4","first-page":"446","volume":"12","author":"LKA Neijenhuis","year":"2022","unstructured":"Neijenhuis LKA, de Myunck L, Bijlstra OD, Kuppen PJK, Hilling DE, Borm FJ, et al. Near-infrared fluorescence tumor-targeted imaging in lung cancer: a systematic review. Life (Basel). 2022;12:446.","journal-title":"Life (Basel)."},{"key":"6365_CR5","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1158\/1078-0432.CCR-12-3598","volume":"19","author":"S Keereweer","year":"2013","unstructured":"Keereweer S, Van Driel PB, Snoeks TJ, Kerrebijn JD, Baatenburg de Jong RJ, Vahrmeijer AL, et al. Optical image-guided cancer surgery: challenges and limitations. Clin Cancer Res. 2013;19:3745\u201354.","journal-title":"Clin Cancer Res."},{"key":"6365_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.suronc.2017.03.002","volume":"26","author":"M Gutowski","year":"2017","unstructured":"Gutowski M, Framery B, Boonstra MC, Garambois V, Quenet F, Dumas K, et al. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery. Surg Oncol. 2017;26:153\u201362.","journal-title":"Surg Oncol"},{"key":"6365_CR7","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/bjc.2012.605","volume":"108","author":"JP Tiernan","year":"2013","unstructured":"Tiernan JP, Perry SL, Verghese ET, West NP, Yeluri S, Jayne DG, et al. Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting. Br J Cancer. 2013;108:662\u20137.","journal-title":"Br J Cancer"},{"key":"6365_CR8","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ejso.2020.10.034","volume":"47","author":"RPJ Meijer","year":"2021","unstructured":"Meijer RPJ, de Valk KS, Deken MM, Boogerd LSF, Hoogstins CES, Bhairosingh SS, et al. Intraoperative detection of colorectal and pancreatic liver metastases using SGM-101, a fluorescent antibody targeting CEA. Eur J Surg Oncol. 2021;47:667\u201373.","journal-title":"Eur J Surg Oncol"},{"key":"6365_CR9","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/bjs.11523","volume":"107","author":"DP Schaap","year":"2020","unstructured":"Schaap DP, de Valk KS, Deken MM, Meijer RPJ, Burggraaf J, Vahrmeijer AL, et al. Carcinoembryonic antigen-specific, fluorescent image-guided cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer. Br J Surg. 2020;107:334\u20137.","journal-title":"Br J Surg"},{"key":"6365_CR10","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1245\/s10434-020-09069-2","volume":"28","author":"KS de Valk","year":"2021","unstructured":"de Valk KS, Deken MM, Schaap DP, Meijer RP, Boogerd LS, Hoogstins CE, et al. Dose-finding study of a CEA-targeting agent, SGM-101, for intraoperative fluorescence imaging of colorectal cancer. Ann Surg Oncol. 2021;28:1832\u201344.","journal-title":"Ann Surg Oncol"},{"key":"6365_CR11","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1245\/s10434-018-6655-7","volume":"25","author":"CES Hoogstins","year":"2018","unstructured":"Hoogstins CES, Boogerd LSF, Sibinga Mulder BG, Mieog JSD, Swijnenburg RJ, van de Velde CJH, et al. Image-guided surgery in patients with pancreatic cancer: first results of a clinical trial using SGM-101, a novel carcinoembryonic antigen-targeting, near-infrared fluorescent agent. Ann Surg Oncol. 2018;25:3350\u20137.","journal-title":"Ann Surg Oncol"},{"key":"6365_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S2468-1253(17)30395-3","volume":"3","author":"LSF Boogerd","year":"2018","unstructured":"Boogerd LSF, Hoogstins CES, Schaap DP, Kusters M, Handgraaf HJM, van der Valk MJM, et al. Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study. Lancet Gastroenterol Hepatol. 2018;3:181\u201391.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"6365_CR13","unstructured":"Vahrmeijer AL. SGM-101 in locally advanced and recurrent rectal cancer (SGM-LARRC). ClinicalTrial.gov. Clinical Trials GOV ID: NCT04642924"},{"key":"6365_CR14","unstructured":"Vahrmeijer AL. Performance of SGM-101 for the delineation of primary and recurrent tumor and metastases in patients undergoing surgery for colorectal cancer. ClinicalTrials.gov. Clinical Trials GOV ID: NCT03659448"},{"key":"6365_CR15","first-page":"e186","volume":"22","author":"S Azargoshasb","year":"2022","unstructured":"Azargoshasb S, Boekestijn I, Roestenberg M, KleinJan GH, van der Hage JA, van der Poel HG, et al. Quantifying the impact of signal-to-background ratios on surgical discrimination of fluorescent lesions. Mol Imaging Biol. 2022;22:e186-95.","journal-title":"Mol Imaging Biol."},{"key":"6365_CR16","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.1016\/S1470-2045(20)30600-8","volume":"22","author":"LJ Lauwerends","year":"2021","unstructured":"Lauwerends LJ, van Driel P, Baatenburg de Jong RJ, Hardillo JAU, Koljenovic S, Puppels G, et al. Real-time fluorescence imaging in intraoperative decision making for cancer surgery. Lancet Oncol. 2021;22:e186\u201395.","journal-title":"Lancet Oncol."},{"key":"6365_CR17","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/diagnostics11030516","volume":"11","author":"D Linders","year":"2021","unstructured":"Linders D, Deken M, van der Valk M, Tummers W, Bhairosingh S, Schaap D, et al. CEA, EpCAM, \u03b1v\u03b26 and uPAR expression in rectal cancer patients with a pathological complete response after neoadjuvant therapy. Diagnostics (Basel). 2021;11:516.","journal-title":"Diagnostics (Basel)."},{"key":"6365_CR18","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.athoracsur.2014.05.026","volume":"98","author":"OT Okusanya","year":"2014","unstructured":"Okusanya OT, Holt D, Heitjan D, Deshpande C, Venegas O, Jiang J, et al. Intraoperative near-infrared imaging can identify pulmonary nodules. Ann Thorac Surg. 2014;98:1223\u201330.","journal-title":"Ann Thorac Surg"},{"key":"6365_CR19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/SLA.0000000000005596","volume":"276","author":"GT Kennedy","year":"2022","unstructured":"Kennedy GT, Azari FS, Chang A, Nadeem B, Bernstein E, Segil A, et al. Comparative experience of short versus long wavelength fluorophores for intraoperative molecular imaging of lung cancer. Ann Surg. 2022;276:711\u20139.","journal-title":"Ann Surg."},{"key":"6365_CR20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.52885","volume":"6","author":"F Azari","year":"2023","unstructured":"Azari F, Meijer RPJ, Kennedy GT, Hanna A, Chang A, Nadeem B, et al. Carcinoembryonic antigen-related cell adhesion molecule type 5 receptor-targeted fluorescent intraoperative molecular imaging tracer for lung cancer: a nonrandomized controlled trial. JAMA Netw Open. 2023;6: e2252885.","journal-title":"JAMA Netw Open"},{"key":"6365_CR21","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/modpathol.2011.82","volume":"24","author":"M D'Angelica","year":"2011","unstructured":"D\u2019Angelica M, Ammori J, Gonen M, Klimstra DS, Low PS, Murphy L, et al. Folate receptor-\u03b1 expression in resectable hepatic colorectal cancer metastases: patterns and significance. Mod Pathol. 2011;24:1221\u20138.","journal-title":"Mod Pathol"},{"key":"6365_CR22","doi-asserted-by":"publisher","first-page":"153303382211417","DOI":"10.1177\/15330338221141795","volume":"21","author":"CI Chen","year":"2022","unstructured":"Chen CI, Li WS, Chen HP, Liu KW, Tsai CJ, Hung WJ, et al. High expression of folate receptor alpha (FOLR1) is associated with aggressive tumor behavior, poor response to chemoradiotherapy, and worse survival in rectal cancer. Technol Cancer Res Treat. 2022;21:15330338221141796.","journal-title":"Technol Cancer Res Treat"},{"key":"6365_CR23","doi-asserted-by":"publisher","first-page":"1179299X1771001","DOI":"10.1177\/1179299X17710016","volume":"9","author":"LSF Boogerd","year":"2017","unstructured":"Boogerd LSF, Vuijk FA, Hoogstins CES, Handgraaf HJM, van der Valk MJM, Kuppen PJK, et al. Correlation between preoperative serum carcinoembryonic antigen levels and expression on pancreatic and rectal cancer tissue. Biomark Cancer. 2017;9:1179299X1771001.","journal-title":"Biomark Cancer."}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06365-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06365-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06365-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T08:05:35Z","timestamp":1722845135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06365-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["6365"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06365-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"assertion":[{"value":"21 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the medical ethical committee \u2018Leiden-Den Haag-Delft\u2019 on February 11, 2020 (ERB reference number: P19.101).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all individual participants included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Figs.\n                      \n                      ,\n                      \n                      ,\n                      \n                      , and\n                      \n                      and supplemental Fig.\u00a0\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"FC and BF are employed by SurgiMab and are co-inventors of the patent that protects SGM-101. FC is also a co-founder of SurgiMab. All other authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}